A prospective longitudinal evaluation of the benefits of epicardial lead placement for cardiac resynchronization therapy

Europace

Volumn 11, Issue 10, 2009, Pages 1323-1329

  Patwala, Ashish ^a   Woods, Paul ^b   Clements, Richard ^b   Albouaini, Khaled ^a   Rao, Archana ^a   Goldspink, David ^b   Tan, Lip Bun ^c   Oo, Aung ^a   Wright, David ^a  

^a LIVERPOOL HEART AND CHEST HOSPITAL   (United Kingdom)

^b LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Cardiac power output; Cardiac reserve; Cardiac resynchronization therapy; Epicardial leads; Exercise testing

Indexed keywords

LEAD;

AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOPULMONARY EXERCISE TEST; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; ECHOCARDIOGRAPHY; EPICARDIAL LEAD PLACEMENT; FEMALE; HUMAN; INTERMETHOD COMPARISON; KIDNEY DISEASE; LOWER RESPIRATORY TRACT INFECTION; MALE; PERICARDIAL EFFUSION; PRIORITY JOURNAL; TRANSVENOUS CORONARY SINUS LEAD PLACEMENT;

AGED; CARDIAC PACING, ARTIFICIAL; ELECTRODES, IMPLANTED; FEMALE; HEART FAILURE; HEART VENTRICLES; HUMANS; LONGITUDINAL STUDIES; MALE; PACEMAKER, ARTIFICIAL; PERICARDIUM; PROSPECTIVE STUDIES; PROSTHESIS IMPLANTATION; TREATMENT OUTCOME;

EID: 70349483979     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eup251     Document Type: Article

References (24)

1. Garg R, Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. J Am Med Assoc 1995;273:1450-1456
2. Cleland JGF, Gemmell I, Khand A, Boddy A. Is the prognosis of heart failure improving? Eur J Heart Failure 1999;1:229-241
3. The CONSENSUS trial group. Effect of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Eng J Med 1987;316:1429-1435
4. Bradley DJ. Combining resynchronization and defibrillation therapies for heart failure. J Am Med Assoc 2003;289:2719-2721
5. Cohn JN, Archibald DG, Ziesche S, Franciosa JA, Harston WE, Tristani FE et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. N Eng J Med 1986; 314:1547-1552
6. National Institute for Clinical Excellence. Chronic heart failure. Management of chronic heart failure in adults in primary and secondary care. Clinical guideline 5. London. NICE 2003;7:57-58.
7. Auricchio A, Stellbrink C, Sack S, Block M, Vogt J, Bakker P et al. Pacing Therapies in Congestive Heart Failure (PATH-CHF) Study Group. Long term clinical effects of hemodynamically optimised cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol 2002;39:2026-2033
8. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T et al. Comparison of Medical Therapy, Pacing, Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Eng J Med 2004; 350:2140-2150
9. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L et al. Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Eng J Med 2005;352:1539-1549
10. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E et al. MIRACLE Study Group. Multicenter InSync Randomized Clinical Evaluation. Cadiac resynchronization in chronic heart failure. N Eng J Med 2002;346: 1845-1853
11. Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B et al. Multi-center InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) Trial Investigators. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure. The MIRACLE ICD Trial. J Am Med Assoc 2003;289:2685-2694
12. Rivero-Ayerza M, De Backer T, Vanderheyden M, Geelen P, Goethals M, de Zutter M et al. Indications for cardiac resynchronization therapy: should they be extended? Eur Heart J Suppl 2003;5:I97-101.
13. Mair H, Sachweh J, Meuris B, Nollert G, Schmoeckel M, Schuetz A et al. Surgical epicardial left ventricular lead versus coronary sinus lead placement in biventricu-lar pacing. Eur J Cardiothorac Surg 2005;27:235-242
14. Doll N, Piorkowski C, Czesla M, Kallenbach M, Rastan AJ, Arya A et al. Epicardial versus transvenous left ventricular lead placement in patients receiving cardiac resynchronization therapy: results from a Randomized Prospective Study. Thorac Cardiovasc Surg 2008;56:256-261
15. Shah RV, Lewis EF, Givertz MM. Epicardial left ventricular lead placement for cardiac resynchronization therapy following failed coronary sinus approach. Congest Heart Fail 2006;12:312-316
16. ACC/AHA 2005. Guideline update for the diagnosis and management of chronic heart failure in the adult. Circulation 2005;112:e154-235.
17. Cooke GA, Marshall P, al-Timman JK, Wright DJ, Riley R, Hainsworth R et al. Physiological cardiac reserve; development of a non-invasive method and first estimates in man. Heart 1998;79:289-294
18. Williams SG, Cooke GA, Wright DJ, Parsons WJ, Riley RL, Marshall P et al. Peak exercise cardiac power output; a direct indicator of cardiac function strongly predictive of prognosis in chronic heart failure. Eur Heart J 2001;22:1496-1503
19. Collier CR. Measurement of mixed venous CO2 tensions by rebreathing. J Appl Physiol 1956;9:25-29
20. Defares JG. Determination of PvCO2 from the exponential CO2 rise during rebreathing. J Appl Physiol 1958;13:159-164
21. Auricchio A, Stellbrink C, Block M, Sack S, Vogt J, Bakker P et al. Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. Circulation 1999;99:2993-3001.
22. Linde C, Leclercq C, Rex S, Garrigue S, Lavergne T, Cazeau S et al. Long-term benefits of biventricular pacing in congestive heart failure: results from the Multi-site STimulation In Cardiomyopathy (MUSTIC) Study. J Am Coll Cardiol 2002;40: 111-118
23. Jansens JL, Jottrand M, Preumont N, Stoupel E, de Cannière D. Robotic-enhanced biventricular resynchronization: an alternative to endovenous cardiac resynchro-nization therapy in chronic heart failure. Ann Thorac Surg 2003;76:413-417
24. Mancini DM, Eisen H, Kussmaul W, Mull R, Edmunds LH Jr, Wilson JR. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 1991;83:778-786